Search Within

Thomas R Tolentino

Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (1)
  2. Department of Medicine (1)
  3. Genitourinary Oncology Service (1)
  4. Nursing (1)
  5. Pediatric Leukemia (1)
  6. Pediatrics, Department of (1)

More Groups

People
  1. Victoria Richon (6)
  2. Paul Marks (5)
  3. Richard Rifkind (5)
  4. Pier Pandolfi Derinaldis (4)
  5. Raymond Warrell (4)
  6. Li-Zhen He (3)

More People

Years
  1. 2001 (2)
  2. 2000 (1)
  3. 1999 (2)
  4. 1998 (1)
Publications
  1. Blood (3)
  2. Clinical Cancer Research (1)
  3. Journal of Clinical Investigation (1)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (1)
Publishers
  1. American Society of Hematology (3)
  2. American Association for Cancer Research (2)
  3. American Society for Clinical Investigation (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia
    Journal Article

    He, L. Z.; Tolentino, T.; Grayson, P.; Zhong, S.; Warrell, R. P. Jr; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Pandolfi, P. P.
    Journal of Clinical Investigation (2001)

    Fulltext@MSK | Save
  • Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
    Journal Article

    Butler, L. M.; Webb, Y.; Agus, D. B.; Higgins, B.; Tolentino, T. R.; Kutko, M. C.; LaQuaglia, M. P.; Drobnjak, M.; Cordon-Cardo, C.; Scher, H. I.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors induce remission in a transgenic model of therapy resistant acute promyelocytic leukemia
    Meeting Abstract

    He, L. Z.; Tolentino, T.; Grayson, P.; Zhong, S.; Warrel, R. P. Jr; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Pandolfi, P. P.
    Blood (2000)

    Fulltext@MSK | Save
  • The hydroxamic acid class of hybrid polar cytodifferentiation agents are potent inhibitors of histone deacetylase activity
    Meeting Abstract

    Richon, V. M.; Tolentino, T.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • Initial clinical evaluation of 'transcription therapy' for cancer: All-trans retinoic acid plus phenylbutyrate
    Meeting Abstract

    Novick, S.; Camacho, L.; Gallagher, R.; Chanel, S.; Ho, R.; Tolentino, T.; Richon, V.; Pandolfi, P. P.; Warrell, R. P.
    Blood (1999)

    Fulltext@MSK | Save
  • Transcription therapy for cancer: Effects of histone deacetylase (HDAC) inhibitors on proliferation, apoptosis and differentiation of leukemic cell lines
    Meeting Abstract

    He, L. Z.; Tolentino, T.; Warrell, R. P.; Zelent, A.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save